Don’t be fooled by Big Pharma’s spin. There is no evidence the proposed Part B changes would impact patient access to drugs.
Patient testimony to call for urgent action in Augusta to lower drug prices.
Bills pass key policy committees as a vote on the floor looms.
First-in-Nation bill to create a Prescription Drug Affordability Board passes House of Delegates.
American patients are standing inside a burning house, and Congress needs to pick up the firehose.
Patients are harmed because high-priced drugs have consequences.
Measure would save money for Utah patients and taxpayers.
We look forward to helping Congress stand up to the drug industry and begin to actually lower drug prices for patients.
Patients For Affordable Drugs Now Takes Major Action in Support of International Pricing Index and Medicare Part B Reforms.
Voters DO NOT buy Big Pharma’s spin that the IPI will harm patient access to drugs
Under the draft proposal from the Department of Health and Human Services, prices for expensive infused drugs administered in physician offices and hospitals would be brought more in line with what people in other wealthy nations pay.
Pharma front group bankrolls $1 million ad buy to smear Part B proposal.
WASHINGTON, DC — Patients in Maine are celebrating the passage of a new law that would help Mainers understand why prescription drugs prices keep rising. Patients For Affordable Drugs NOW, a patient advocacy organization, applauded passage of the bill.
“My 5-year-old son, Dakota, needs insulin to live,” said Sabrina Burbeck, a single mom who lives in Old Town. "When drug corporations charge $200-a-vial for a drug invented in the 1920s, we should all worry and demand change. There is no justifiable reason that his insulin costs keep going up, and the fear of my son losing his life-saving medicine keeps me up at night.”
A bipartisan group of Maine state legislators passed LD 1406 in April. The legislation, which became law yesterday, allows the Maine Health Data Organization to gather information from drug corporations about their pricing practices and to report its findings to citizens in Maine.
Patients For Affordable Drugs NOW is a bipartisan advocacy organization focused exclusively on policies to lower drug prices. To maintain its independence, P4ADNOW does not accept funding from organizations that profit from the development or distribution of prescription drugs.
For Maine patient interviews, contact Juliana Keeping.